Public-registry site landscape for NCT03382977, a Glioblastoma Multiforme study sponsored by VBI Vaccines Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03382977 (registry record) |
| Sponsor | VBI Vaccines Inc. |
| Condition(s) | Glioblastoma Multiforme |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 12 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03382977 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →